ULK1: a promising biomarker in predicting poor prognosis and therapeutic response in human nasopharygeal carcinoma.

ULK1: a promising biomarker in predicting poor prognosis and therapeutic response in human nasopharygeal carcinoma.

Plenty of studies have established that dysregulation of autophagy plays an essential role in cancer progression. The autophagy-related proteins have been reported to be closely associated with human cancer patients' prognosis. We explored the expression dynamics and prognostic value of autopha...

Full description

Bibliographic Details
Main Authors:	Miao Yun, Hai-Yan Bai, Jia-Xing Zhang, Jian Rong, Hui-Wen Weng, Zhou-San Zheng, Yi Xu, Zhu-Ting Tong, Xiao-Xia Huang, Yi-Ji Liao, Shi-Juan Mai, Sheng Ye, Dan Xie
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2015-01-01
Series:	PLoS ONE
Online Access:	http://europepmc.org/articles/PMC4340914?pdf=render

Similar Items

The Biological Interaction of Bcl-2, p53 and LMP1 in Nasopharygeal Carcinoma Cells
by: 翁偉平
Published: (1998)

ULK1 as a novel therapeutic target in neurodegeneration
by: Björn Friedhelm Vahsen, et al.
Published: (2021-01-01)

The Biological Effects of Bcl-2 and Epstein-Barr Virus-Encoded Latent Membrance Protein 1 in Nasopharygeal Carcinoma Cells
by: 劉齊芳
Published: (1997)

The role of ULK1 and ULK2 in Autophagy Regulation
by: Lee, Eunju
Published: (2010)

The incredible ULKs
by: Alers Sebastian, et al.
Published: (2012-03-01)

Aurora-A identifies early recurrence and poor prognosis and promises a potential therapeutic target in triple negative breast cancer.
by: Jie Xu, et al.
Published: (2013-01-01)

ULK1 and ULK2 modulate different aspects of skeletal muscle autophagy
by: Mere, Caleb Patrick
Published: (2017)

Apoptosis-associated biomarkers in tuberculosis: promising for diagnosis and prognosis prediction
by: Shu Chin-Chung, et al.
Published: (2013-01-01)

ULK1 Inhibition as a Targeted Therapeutic Strategy for Psoriasis by Regulating Keratinocytes and Their Crosstalk With Neutrophils
by: Xiaonan Qiu, et al.
Published: (2021-08-01)

OBEZİTE VERGİSİ ÜLKE UYGULAMALARI
by: Işıl AYAS, et al.
Published: (2017-12-01)

PGM5 is a promising biomarker and may predict the prognosis of colorectal cancer patients
by: Yifan Sun, et al.
Published: (2019-10-01)

ER-Targeted Beclin 1 Supports Autophagosome Biogenesis in the Absence of ULK1 and ULK2 Kinases
by: Tahira Anwar, et al.
Published: (2019-05-01)

Ulk1, Not Ulk2, Is Required for Exercise Training-Induced Improvement of Insulin Response in Skeletal Muscle
by: Joshua C. Drake, et al.
Published: (2021-09-01)

MXRA5 Is a Novel Immune-Related Biomarker That Predicts Poor Prognosis in Glioma
by: Jin-Zhang Sun, et al.
Published: (2021-01-01)

The Role of ULK1 in the Pathophysiology of Osteoarthritis
by: Abou Rjeili, Mira
Published: (2016)

CD26 as a Promising Biomarker for Predicting Prognosis in Patients with Pancreatic Tumors
by: Yan L, et al.
Published: (2020-12-01)

TSPO: an emerging role in appetite for a therapeutically promising biomarker
by: Joshua Wang, et al.
Published: (2021-08-01)

Non-coding RNAs in depression: Promising diagnostic and therapeutic biomarkers
by: Yachen Shi, et al.
Published: (2021-09-01)

PDIA4 Correlates with Poor Prognosis and is a Potential Biomarker in Glioma
by: Li H, et al.
Published: (2021-01-01)

A Novel Biomarker Driving Poor-Prognosis Liver Cancer: Overexpression of the Mitochondrial Calcium Gatekeepers
by: Chia-Jung Li, et al.
Published: (2020-10-01)

Identification of four hub genes as promising biomarkers to evaluate the prognosis of ovarian cancer in silico
by: Jingxuan Chen, et al.
Published: (2020-06-01)

MicroRNA: a new and promising potential biomarker for diagnosis and prognosis of ovarian cancer
by: Manish K. Pal, et al.
Published: (2015-12-01)

Annexin 1—a promising biomarker for prognosis of Taiwan bladder transitional cell carcinoma
by: Ping-hsun Feng, et al.
Published: (2010)

Biomarker exploration of microRNA-203 as a promising substrate for predicting poor survival outcome in colorectal cancer
by: Qiliang Peng, et al.
Published: (2020-10-01)

ULK1 Phosphorylates and Regulates Mineralocorticoid Receptor
by: Shigeru Shibata, et al.
Published: (2018-07-01)

The association of AMPK with ULK1 regulates autophagy.
by: Jong Woo Lee, et al.
Published: (2010-11-01)

Rap2c as a Novel Biomarker for Predicting Poor Prognosis in Glioma
by: Wang X, et al.
Published: (2020-04-01)

Validation of podocalyxin-like protein as a biomarker of poor prognosis in colorectal cancer
by: Larsson Anna, et al.
Published: (2012-07-01)

Tgf-β1 expression as a biomarker of poor prognosis in prostate cancer
by: Sabrina Thalita dos Reis, et al.
Published: (2011-01-01)

Identification of microRNA‐181 as a promising biomarker for predicting the poor survival in colorectal cancer
by: Qiliang Peng, et al.
Published: (2019-10-01)

Ülke İmajının Satın Alma İstekliliği Üzerindeki Etkisinde Tüketici Yakınlığı, Ürün-Ülke İmajı ve Ürün Yargılarının Aracılık Rolü
by: Elif Ülker Demirel
Published: (2021-06-01)

An Omics Perspective on Molecular Biomarkers for Diagnosis, Prognosis, and Therapeutics of Cholangiocarcinoma
by: Pattaya Seeree, et al.
Published: (2015-01-01)

Molecular and Clinical Characterization of UBE2S in Glioma as a Biomarker for Poor Prognosis and Resistance to Chemo-Radiotherapy
by: Li Hu, et al.
Published: (2021-05-01)

Ruxolitinib as a Novel Therapeutic Option for Poor Prognosis T-LBL Pediatric Patients
by: Giulia Veltri, et al.
Published: (2021-07-01)

ULK1 inhibition as a targeted therapeutic strategy for FLT3-ITD-mutated acute myeloid leukemia
by: Doh Yu Hwang, et al.
Published: (2020-05-01)

High expression of IMPDH2 is associated with aggressive features and poor prognosis of primary nasopharyngeal carcinoma
by: Yi Xu, et al.
Published: (2017-04-01)

The Promising IgSF11 Immune Checkpoint Is Highly Expressed in Advanced Human Gliomas and Associates to Poor Prognosis
by: Amina Ghouzlani, et al.
Published: (2021-02-01)

microRNA-944 overexpression is a biomarker for poor prognosis of advanced cervical cancer
by: Sunyoung Park, et al.
Published: (2019-05-01)

Serum Albumin as a Biomarker of Poor Prognosis in the Pediatric Patients in Intensive Care Unit
by: Young Suh Kim, et al.
Published: (2017-11-01)

Angiotensinogen rs5050 germline genetic variant as potential biomarker of poor prognosis in astrocytoma.
by: Alexander Perdomo-Pantoja, et al.
Published: (2018-01-01)